23214 results for "ega"

in 21.59 milliseconds.

• Single-nucleus fixed mRNA profiling of FFPE samples

  Single-nucleus fixed mRNA profiling of FFPE samples from patients after sex-mismatched blood stem cell transplantation and matched controls.

  Dataset EGAD50000000047

• Single-cell somatic copy number variants in brain using different amplification methods and reference genomes

  This dataset contains 224 paired fastq files (112 single cells) from the following samples: brains from two Multiple System Atrophy patients and one control, and non-brain controls (fibroblasts, NA12878)

  Dataset EGAD50000000030

• Long read mRNA sequencing of human neural retinal samples

  Long-read (PacBio) RNA sequencing dataset of three neural retinal samples. Files are raw BAM format files generated by a Sequel II machine. Additionally, the ccs3 BAM format files are included.

  Dataset EGAD50000000101

• Transcriptomic sequencing of early and late passage of mCRC tumoroids

  Dataset of 46 mCRC tumoroids from different passages (23 early-passage 3, 23 late-passage 8-12). FASTQ files of paired sequencing of PolyA-enriched total RNA

  Dataset EGAD50000000153

• LCM isolated buccal epithelial cell WGS of chimeric twins

  Buccal epithelial cells of chimeric twins were isolated using laser-capture microdissection. Cells were pooled (13-60 cells) per batch to create a genomic DNA library using an NEB low-input kit.

  Dataset EGAD50000000131

• AmsterdamUMC Data Access Committee for the MAPS study

  The current data access committee reviews and assesses data requests of researchers that seek to gain access to data acquired from the MAping the Peritoneal immune System (MAPS) project as performed at the AmsterdamUMC, Amsterdam, Netherlands.

  Dac EGAC50000000096

• 10X Chromium 5' scRNA, scTCR and scBCR sequencing of pre- and on-treatment HNSCC biopsy samples

  We performed 10X Chromium 5' scRNA (n=50), scTCR (n=48) and scBCR (n=49) sequencing of pre- and on-treatment HNSCC biopsy samples.

  Dataset EGAD50000000056

• Sensitive circulating tumor DNA based residual disease detection in epithelial ovarian cancer

  We analyzed 264 plasma samples collected between June 2016 and September 2021 from 63 epithelial ovarian cancer patients using tumor-guided plasma cell-free DNA analysis to detect residual disease after treatment.

  Dataset EGAD50000000360

• Framome cancer samples

  Cancer samples for neo-open reading frame peptides that comprise the tumor framome are a rich source of neoantigens for cancer immunotherapy.

  Dataset EGAD50000000420

• Whole genome sequencing data of high-grade serous ovarian cancer samples (set 10)

  Whole genome sequencing data of 56 high-grade serous carcinoma (HGSC) patients (208 samples) sequenced with Novoseq 6000

  Dataset EGAD50000000275